TrialLupus science & medicine2024

Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease.

Scott R P McDonnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.